Controversial Strategy: Selling Patents to a Native American Tribe
Posted on Dec 4, 2017 in Articles
Allergan (a pharmaceutical company) is the manufacturer of Restasis, a prescription eye drop that is used to treat Chronic Dry Eye disease by increasing tear production. Restasis has been a commercial success, with sales in 2016 of approximately $1.5 billion, and Allergan’s website states that its formulation has been “prescribed 6.4 million times since 2003.” Restasis is patented, and those patents received significant attention last month when they were sold to a Native American tribe—as a litigation strategy.
Read MoreCR Partner Appointed Co-Chair of Printing-for-Digital Fabrication Conference
Posted on Nov 9, 2017 in News
CR Partner Scott Slomowitz has been appointed publicity co-chair for the Printing-for-Digital Fabrication Conference, sponsored by the Society for Imaging Science and Technology, to be held in Dresden, Germany in September 2018.
Read MoreDon’t Let Your Trademark Become Generic
Posted on Oct 25, 2017 in Articles
A music video went viral this month, but it’s doubtful you know any of its musicians. The tune is quite catchy, and the performance is not only professional, but very enjoyable. What is the theme of the song? Coming of age? A broken heart? No. It’s a music video about Velcro Brand Fasteners and the VELCRO trademark.
Read MoreWhy Patent Claims Language Must Be Clearly Written
Posted on Sep 27, 2017 in Articles
Everyday business communication is hard enough. With all of the subtleties and nuances of language, the message received by an individual may not match what was intended. But with patent claims, the need for definiteness is far greater.
Read MoreCR Client LifeAire Systems’ Patented System Used by Top Fertility Lab in U.S.
Posted on Sep 18, 2017 in Blog
LifeAire Systems, a leader in air purification for healthcare, announced that the in vitro fertilization (IVF) program with the highest live-birth rate for women under 35 according to 2015 data uses LifeAire’s patented Aire~IVF® System.
Read MorePatent Unenforceable Based on Inequitable Conduct
Posted on Aug 23, 2017 in Articles
It’s been called the atomic bomb of patent law—inequitable conduct. It happens when a patent is applied for, but the duty of candor, disclosure and good faith toward the U.S. Patent and Trademark Office (USPTO) is violated. If proven to have occurred during patent procurement, then the entire resulting patent becomes unenforceable.
Read MoreCR Partner Featured in Academy of Court Appointed Masters Newsletter
Posted on Aug 23, 2017 in News
Caesar Rivise Partner James Kozuch is featured in the August 2017 Academy of Court Appointed Masters (ACAM) Newsletter. The ACAM newsletter spotlights BIEC International, Inc. v. Global Steel Services, Ltd. et al., a complex trade secrets case between two steel-makers in which Mr. Kozuch served as a Special Master.
Read MoreAssociation of Intellectual Property Firms Annual Meeting in San Francisco
Posted on Aug 16, 2017 in Events
This year the AIPF’s Annual Meeting takes place from September 13th – 15th at the Marriott Fisherman’s Wharf Hotel in San Francisco, California. The Annual Meeting is an excellent opportunity for IP practitioners to meet in person and establish personal and business connections, as well as obtain beneficial information in a cordial environment.
Read MoreTrademarks and the First Amendment Considered by Supreme Court
Posted on Jul 26, 2017 in Articles
When I studied constitutional law in law school, one subject was certainly never mentioned in that class: trademarks. After last month’s U.S. Supreme Court decision in Matal v. Tam, that may change.
Read MoreSignificant Change in Patent Exhaustion From the Supreme Court
Posted on Jun 21, 2017 in Articles
When was the last time you sold your used car and worried about infringing the patent rights of the manufacturer? My guess is you would say “never.”
Read More